To investigate whether ginsenoside Rg3 could exert potentiating anti-cancer effects on EGFR-TKI agents by down-regulating the copy number and expression of EGFR protein, we performed mouse tumor-loading experiments. The gene discussed is EGFR; the disease is neoplasm.